September 2017 Issue of The Ophthalmologist

It takes work. But it's more than worth it, when done intelligently.

Protocol I subanalysis suggests that earlier treatment of DME eyes with persistent edema maximizes visual benefit.

Research shows that art training can improve ophthalmologists’ observational skills.

Bioactive lipids show promise in protecting against the development of neovascular disease.

How do patients really feel about their disease – and how do they differ.

This month’s approvals, acquisitions, revenue reports, regulatory action and trial results.

An image of corneal dystrophy.

Glaucoma management works best as a team approach - with the patient at the helm.

Lessons in taking a more active role in diabetes care.

How three leading lights and one CEO are tackling corneal disease through pioneering research and development.

The first clinical trial of autologous adipose-derived adult stem cells for the treatment of corneal ectatic disorders.

Can the cornea be "revived" with cadaveric allograft material?

Monty Montoya and Shigeru Kinoshita on bringing endothelial cell therapy to patients.

How measuring dark adaptation could help diagnose AMD earlier.

How one organization and a flagship aircraft are changing the lives of millions across the globe.

Richard Lindstrom, Chairman and Founder of Minnesota Eye Consultants, Minneapolis, Minnesota, USA.

Five experts answered key questions on Ultrasound Cyclo Plasty (UCP) at a symposium held during the WGC-2017 annual meeting.

How new optics are giving patients good distance, intermediate and near vision – and smooth transitions in between.

Highlights from the Milan 2017 SIFI User Meeting

Meet the Masters of the new comprehensive MIGS